These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22744392)

  • 1. Predictors of outcome in fungal keratitis.
    Prajna NV; Krishnan T; Mascarenhas J; Srinivasan M; Oldenburg CE; Toutain-Kidd CM; Sy A; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Porco TC
    Eye (Lond); 2012 Sep; 26(9):1226-31. PubMed ID: 22744392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
    Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
    Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Das M; Ray KJ; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2017 Sep; 135(9):987-991. PubMed ID: 28817744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
    Prajna NV; Mascarenhas J; Krishnan T; Reddy PR; Prajna L; Srinivasan M; Vaitilingam CM; Hong KC; Lee SM; McLeod SD; Zegans ME; Porco TC; Lietman TM; Acharya NR
    Arch Ophthalmol; 2010 Jun; 128(6):672-8. PubMed ID: 20547942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pretreatment with antifungal agents on clinical outcomes in fungal keratitis.
    Sun CQ; Prajna NV; Krishnan T; Rajaraman R; Srinivasan M; Raghavan A; O'Brien KS; McLeod SD; Acharya NR; Rose-Nussbaumer J;
    Clin Exp Ophthalmol; 2016 Dec; 44(9):763-767. PubMed ID: 27329780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
    Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
    JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
    Arora R; Gupta D; Goyal J; Kaur R
    Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
    Pickel J; Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Porco TC; Redd T; Lietman TM; Rose-Nussbaumer J
    Am J Ophthalmol; 2020 Jul; 215():1-7. PubMed ID: 32171765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.
    Lalitha P; Prajna NV; Oldenburg CE; Srinivasan M; Krishnan T; Mascarenhas J; Vaitilingam CM; McLeod SD; Zegans ME; Porco TC; Acharya NR; Lietman TM
    Cornea; 2012 Jun; 31(6):662-7. PubMed ID: 22333662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Significance of Repeat Cultures in the Treatment of Severe Fungal Keratitis.
    Ray KJ; Prajna NV; Lalitha P; Rajaraman R; Krishnan T; Patel S; Das M; Shah R; Dhakhwa K; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    Am J Ophthalmol; 2018 May; 189():41-46. PubMed ID: 29438654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
    Sharma S; Das S; Virdi A; Fernandes M; Sahu SK; Kumar Koday N; Ali MH; Garg P; Motukupally SR
    Br J Ophthalmol; 2015 Sep; 99(9):1190-5. PubMed ID: 25740805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Srinivasan M; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Porco TC; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2016 Dec; 134(12):1365-1372. PubMed ID: 27787540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
    Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
    Ann Pharmacother; 2009 Jun; 43(6):1139-42. PubMed ID: 19435962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scedosporium Keratitis: An Experience From a Tertiary Eye Hospital in South India.
    Rathi HS; Venugopal A; Rengappa R; Ravindran M
    Cornea; 2016 Dec; 35(12):1575-1577. PubMed ID: 27538191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Utility of Repeat Culture in Fungal Corneal Ulcer Management: A Secondary Analysis of the MUTT-I Randomized Clinical Trial.
    Ray KJ; Lalitha P; Prajna NV; Rajaraman R; Krishnan T; Srinivasan M; Ryg P; McLeod S; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    Am J Ophthalmol; 2017 Jun; 178():157-162. PubMed ID: 28385473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The successful medical treatment of a case of Paecilomyces lilacinus keratitis.
    Wu PC; Lai CH; Tan HY; Ma DH; Hsiao CH
    Cornea; 2010 Mar; 29(3):357-8. PubMed ID: 20098311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
    Rose-Nussbaumer J; Prajna NV; Krishnan KT; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; McLeod SD; Porco TC; Lietman TM; Acharya NR; Keenan JD;
    JAMA Ophthalmol; 2015 Jun; 133(6):642-6. PubMed ID: 25764482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.
    Rose-Nussbaumer J; Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; Porco TC; McLeod SD; Acharya NR; Keenan JD; Lietman TM;
    Br J Ophthalmol; 2016 Jul; 100(7):929-932. PubMed ID: 26531051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of microsporidia keratitis with topical voriconazole monotherapy.
    Khandelwal SS; Woodward MA; Hall T; Grossniklaus HE; Stulting RD
    Arch Ophthalmol; 2011 Apr; 129(4):509-10. PubMed ID: 21482878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.